John Belizaire
About John Belizaire
John Belizaire (age 53) is CEO of Soluna Holdings (since May 1, 2023) and a director since 2021; he previously led Soluna Computing and Soluna Callisto. He holds B.S. and M.Eng. degrees in Computer Science from Cornell and completed Wharton’s Executive Development Program, with a career spanning multiple founder/CEO roles and growth equity advisory positions . Pay-versus-performance shows 2024 TSR of $53 vs $62 in 2023 (base $100), while net loss widened to $(58.3)M in 2024 from $(27.7)M in 2023, indicating negative shareholder return and earnings pressure during his CEO tenure . Revenues grew year over year in 2024, but EBITDA and net income declined; see performance table below (S&P Global) and governance/operational notes (internal control material weakness in Q3’25, and major project execution milestones) .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Soluna Holdings, Inc. | Chief Executive Officer | 2023–present | Transitioned to public-co CEO; steered capital and growth agenda |
| Soluna Computing, Inc. | CEO and Board member | 2021–present | Built renewable computing pipeline; integration into SHI |
| Soluna Callisto (pre-merger) | Chief Executive Officer | 2018–2021 | Led business through acquisition by SHI |
| FirstBest Systems | Co‑Founder & CEO | 2006–2016 | Built and exited to Guidewire; insurance software leadership |
| Guidewire Software | Senior Industry Advisor | 2016–2017 | Industry strategy post-acquisition |
| TheoryCenter (acq. by BEA) | Co‑Founder, President & CEO | 1990s–1999 | Founded enterprise software co.; exit to BEA |
| BEA Systems | Senior Director, Bus. Dev. & Strategy | 1999–2002 | Post-merger strategy execution |
| NextStage LLC | Managing Partner (VC) | 2002–2016 | Early-stage investing and scaling expertise |
External Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Pilot Growth Equity Partners | Operating Advisor | 2020–present | Growth equity portfolio support |
| Center for American Entrepreneurship | Board of Directors | 2020–present | Policy/advocacy for entrepreneurship |
| Harmattan Energy Ltd. (HEL) | Director; personal equity stake | Ongoing | Related-party counterparty in legacy transactions |
Fixed Compensation
| Metric | 2023 | 2024 |
|---|---|---|
| Base Salary ($) | 424,815 | 450,000 |
| Cash Bonus ($) | Not disclosed in SCT | Not disclosed in SCT |
| Stock Awards – Grant Date Fair Value ($) | — | 1,718,244 |
| All Other Compensation ($) | 16,993 | 13,800 |
| Total ($) | 441,808 | 2,182,044 |
Notes:
- Amended and Restated Employment Agreement (Nov 20, 2023): CEO base salary set at $450,000 (retroactive adjustment to May 1, 2023), cost-of-living adjustments, annual performance bonuses under 2023 plan based on key performance objectives (no target % disclosed) .
Performance Compensation
| Plan/Instrument | Metric(s) | Weighting | Target | Actual/Payout | Vesting |
|---|---|---|---|---|---|
| Annual Cash Bonus (Company CEO) | Key Performance Objectives | Not disclosed | Not disclosed | Not disclosed | N/A |
| RSAs/Preferred RSAs (2024 grants) | Service-based | N/A | N/A | N/A | Time-vest (see schedules below) |
| Prior SCI Agreement (legacy) | Bonus up to $175,000 (SCI role) | Not disclosed | $175,000 max | Not disclosed | RSUs proportionally vest based on KPI attainment; full vest at 100%; unvested RSUs accelerate on CoC or termination w/o cause or for good reason (SCI) |
- Clawback: Board-adopted policy to recover “excess” incentive compensation (cash/equity) tied to financial reporting measures for current/former executive officers upon accounting restatement, irrespective of misconduct .
- Anti‑hedging: Prohibits hedging transactions (e.g., puts, calls, derivatives) by directors/officers/employees .
Equity Grants (2024 detail)
| Grant date | Award type | Shares/Units | Notes |
|---|---|---|---|
| Apr 15, 2024 | Restricted Stock Awards (Common) | 141,176 | Service-vesting |
| Apr 15, 2024 | Restricted Series A Preferred | 100,000 | Service-vesting |
| Jun 1, 2024 | Restricted Stock Awards (Common) | 21,361 | Service-vesting |
| Sep 1, 2024 | Restricted Stock Awards (Common) | 170,800 | Service-vesting |
| Dec 1, 2024 | Restricted Stock Awards (Common) | 153,745 | Service-vesting |
| 2024 Total Fair Value ($) | — | — | 1,718,244 (SCT grant-date fair value) |
Options: None reported for Belizaire outstanding as of Dec 31, 2024 (Toporek only shows options) .
Vesting Schedules and Overhang
| Tranche | Vesting schedule | Shares |
|---|---|---|
| 2024 RSAs (granted Jun 1, 2024) | 33% vested on Jun 1, 2025; 33% on Jun 1, 2026; 34% on Jun 1, 2027 (service-based) | 181,294 |
| 2024 RSAs (granted Sep 1, 2024) | 33% on Sep 1, 2025; 33% on Sep 1, 2026; 34% on Sep 1, 2027 (service-based) | 152,043 |
| 2024 RSAs (granted Dec 1, 2024) | 33% on Dec 1, 2025; 33% on Dec 1, 2026; 34% on Dec 1, 2027 (service-based) | 153,745 |
| 2025 RSAs (granted Jun 1, 2025) | 33% on Jun 1, 2026; 33% on Jun 1, 2027; 34% on Jun 1, 2028 (service-based) | 309,004 |
| 2025 RSAs (granted Sep 1, 2025) | 33% on Sep 1, 2026; 33% on Sep 1, 2027; 34% on Sep 1, 2028 (service-based) | 416,394 |
Implications: Multiple time-based RSAs vesting through 2028 create periodic supply overhang and potential selling pressure if not covered by 10b5‑1 plans; company-level policy prohibits hedging but does not disclose pledging prohibitions; no executive ownership guidelines in place .
Equity Ownership & Alignment
| Date | Beneficial ownership (shares) | % of class | Notes |
|---|---|---|---|
| Jun 30, 2025 | 805,306 | 4.2% | Includes multiple RSA tranches vesting 2025–2028 |
| Sep 29, 2025 | 1,221,700 | 1.9% | Reflects larger share count; detailed tranches in footnotes |
- Executive stock ownership guidelines: None (company states it does not impose ownership guidelines on executives) .
- Anti-hedging: Prohibited; pledging not specifically disclosed .
Employment Terms
- Current Agreement: Amended and Restated Employment Agreement dated Nov 20, 2023; CEO term from May 1, 2023 through Dec 31, 2027, auto-renewing annually unless 90-day notice; base salary $450,000 with COLA and bonus eligibility under 2023 plan; standard benefits .
- Severance: If terminated without cause or resignation for good reason, payment of six months of base salary over six months, 18 months of health coverage, plus earned and pro‑rated bonuses per terms; accrued benefits; release required .
- Legacy SCI Agreement (Oct 29, 2021): Salary $350,000; annual bonus up to $175,000; annual RSUs up to $175,000; sign‑on RSUs ~$811,410 with cliff+monthly vest; unvested RSUs fully vest on termination without cause/for good reason or upon change of control (SCI) .
- Restrictive Covenants: Proprietary rights, confidentiality, non‑solicitation and non‑compete (SCI agreement); restrictive covenants referenced in amended CEO agreement .
Company Performance Context (for pay-for-performance)
| Metric (USD) | FY 2023 | FY 2024 |
|---|---|---|
| Revenues | 10.196 M * | 18.854 M* |
| EBITDA | (6.289) M* | (31.753) M* |
| Net Income (IS) | (29.201) M* | (63.334) M* |
Values retrieved from S&P Global.
Notes: 2024 revenues grew YoY, while EBITDA and net income declined materially; aligns with disclosed higher stock-based compensation expense and legal/professional costs .
Pay vs Performance and TSR:
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Value of $100 investment (TSR) | 228 | 62 | 53 |
| Net Loss ($000s) | (99,095) | (27,703) | (58,300) |
Performance & Track Record
- Execution: Completed and fully energized Project Dorothy 2 (48 MW), bringing total energized capacity to 123 MW and >5 EH/s, with reported on-time/on-budget delivery; highlights scaling capability in renewable-powered compute . Monthly updates further show progress across sites and partnerships (e.g., KULR at Project Sophie, Kati build-out) .
- Controls/Reporting: Management concluded disclosure controls and procedures were not effective as of Sep 30, 2025 due to material weaknesses (EPS calculation involving unvested RSAs; accounting for derivative warrant liabilities); remediation underway .
- Capital Structure Actions: 2025 reverse split authorization sought (1:5 to 1:50) to maintain Nasdaq listing; 2025 special proxy to increase authorized common shares from 75M to 375M to facilitate financing/equity plans; 2024 SEPA and Series B amendments enabling capital access and significant equity reserve increases for plans. These indicate dilution risk and capital dependence during growth .
Board Governance
- Roles: John Belizaire serves as CEO and Director (non‑independent) .
- Board leadership: Michael Toporek serves as Executive Chairman (non‑independent); William P. Phelan serves as Lead Independent Director, with separation of CEO and chair roles; Board met 26 times in 2024, with ≥75% attendance by each director .
- Committees: Audit (Marusak Chair; all independent), Compensation (Phelan Chair; all independent), Nominating & Governance (Hirshfield Chair; all independent), Executive Committee (majority independent; authority includes authorizing equity sale pricing) .
- Lender oversight: Credit facility grants lender a non‑voting Board observer right with exclusions for sensitive committee matters; confidentiality and conflicts provisions apply .
- Director compensation: Non‑employee directors receive $20k retainer; committee chair fees ($15k); lead independent premium ($10k); Executive Committee member fee ($15k). Employees (including CEO) are not paid for Board service .
Director Compensation (as a director)
- Not applicable (CEO is not compensated for Board service) .
Related Party Transactions
- HEL Transactions: Company engaged in transactions with HEL (affiliates of Brookstone); independent committee and separate counsel utilized. Belizaire serves as HEL director and owner (~10.54% direct plus indirect interests); Company’s HEL equity interest was fully impaired in 2022. Exposure highlights governance/related‑party oversight processes .
Compensation Structure Analysis
- 2024 pay mix skewed to equity (SCT: stock awards $1.72M vs salary $0.45M), aligning pay to stock, but amid negative TSR and larger net loss, raises pay‑for‑performance scrutiny; absence of disclosed bonus metrics/targets reduces transparency .
- Equity plan share reserve increased and authorized shares expanded, suggesting continued reliance on equity for retention/capital—investor dilution risk .
- Executive ownership guidelines absent; anti‑hedging in place; no tax gross‑ups disclosed; no option repricing disclosed .
Risk Indicators & Red Flags
- Material weaknesses in ICFR (EPS and complex equity accounting) .
- Significant dilution potential (SEPA; increased plan reserves; 2025 authorized share increase; reverse split authority) .
- Related‑party linkages (HEL; Brookstone affiliations); mitigated by independent committee process .
- No executive ownership guidelines; potential alignment gap .
Investment Implications
- Alignment: Heavy equity-based compensation and sizable personal holdings align CEO incentives with equity value; however, absence of ownership guidelines and large time-based RSA overhang through 2028 can create periodic selling pressure risk .
- Execution vs. control risk: Strong delivery on Project Dorothy 2 and pipeline activity are positives, but material control weaknesses and continued operating losses warrant a discount and sustained governance focus .
- Dilution/financing overhang: SEPA, reverse split preparedness, and authorized share increase point to ongoing equity financing needs; monitor equity issuance cadence and plan utilization .
- Governance: Separation of CEO and Executive Chairman with a Lead Independent Director and independent key committees helps oversight; lender observer rights add transparency but also complexity. Related‑party history underscores the need to track committee independence and approvals on future transactions .
Appendix: Additional ownership context (as of special proxies)
- Beneficial ownership at Sep 29, 2025 lists Belizaire at 1,221,700 shares (1.9%) with detailed RSA vesting schedules; group (directors/officers) at 10.1% .
- Mid‑2025 ownership (June 30, 2025): Belizaire 805,306 shares (4.2%); group at 23.7% amid smaller share count pre‑subsequent issuances .
Appendix: Control and stock comp disclosures (Q3’25 10‑Q)
- Stock‑based compensation for nine months ended Sep 30, 2025 increased by ~$2.4M YoY, reflecting grants to directors/officers in 2024–2025 and employee grants; SAL/benefits up on performance bonuses settled Oct 2025; professional/legal fees up on SEC, Project Kati, and complex accounting support .
Notes on performance table: Values retrieved from S&P Global.